Mechanism of Action Glucocorticoid-induced osteoporosis (GIO) is the second most prevalent cause of osteoporosis after postmenopausal estrogen deficiency. Glucocorticoids have both direct and ...

Commonly used calcium supplement Shelcal 500 and antacid Pan D are among the four drugs flagged as spurious by the Central ...

Eladynos – which is only the second osteoporosis drug to reach UK patients in the last 15 years – could now find a role as an alternative to Evenity and Forsteo, is seen as an important ...

Another drug listed on the rebate list is Evenity, a drug intended to treat osteoporosis in postmenopausal women. Per Eventiy's website, Evenity can cost up to $2,503.74 per month. However ...

Nonadherence to pharmacological treatment in osteoporosis is a well-recognized problem. As in other chronic diseases, adherence to osteoporosis treatment is poor, resulting in enormous burden on ...

CSIR-Central Drug Research Institute (CDRI) has identified the protein sclerostin as a potential target for treating osteoporosis and fractures related to chronic kidney disease (CKD). In ...